In FL-HCC, the DNAJB1-PRKACA fusion transcript is detectable in 100% of patients and has been identified as the oncogenic driver in tumor pathogenesis25,26 indicating expression of the fusion transcript in all tumor cells. This evidence concerns the gene DNAJB1 and hepatocellular carcinoma.